ACL Mechanical Property Changes in Female Collegiate Basketball Players During a Competitive Season

March 17, 2026 updated by: Fu Jen Catholic University Hospital

Mechanical Properties and Performance of the Anterior Cruciate Ligament in Female Basketball Players Before and After the Season

This prospective cohort study aims to investigate whether the mechanical properties of the anterior cruciate ligament (ACL) undergo measurable changes throughout a competitive basketball season in female collegiate athletes. Female athletes are at a significantly higher risk for non-contact ACL injuries compared to males. Beyond acute injuries, cumulative stress from high-intensity sports may lead to subclinical alterations in the ligament's biomechanical properties, potentially increasing injury risk.

Using non-invasive shear wave elastography (SWE) and countermovement jump (CMJ) tests, the study will monitor 60 elite players before and after the University Basketball League (UBL) season. The findings will help identify potential signs of cumulative loading and contribute to the development of early detection markers for injury risk in female athletes.

Study Overview

Detailed Description

[Introduction and Rationale] The anterior cruciate ligament (ACL) is a critical stabilizer of the knee joint, particularly during high-demand athletic activities involving pivoting, rapid deceleration, and landing. Female athletes exhibit a significantly higher incidence (2 to 9 times) of non-contact ACL injuries compared to their male counterparts. While acute trauma is a well-recognized mechanism, emerging evidence suggests that cumulative loading over a competitive season may lead to subclinical alterations in the ligament's mechanical properties. These changes, such as decreased stiffness, may predispose athletes to injury by compromising joint stability and neuromuscular control. However, objective in vivo data regarding the seasonal adaptation of the ACL in elite athletes remains sparse.

[Study Design and Participants] This prospective cohort study will recruit 60 elite female collegiate basketball players from Division I teams of the University Basketball Association (UBA). The research is designed to track longitudinal changes in ACL integrity and functional performance across a full competitive season.

[Study Procedures]

Participants will undergo standardized assessments at two distinct time points:

Pre-season Assessment (Baseline): Conducted in October, prior to the start of the competitive UBL season.

Post-season Assessment: Conducted in April, following the conclusion of the competitive basketball season.

During each session, two primary modalities will be employed:

  1. Imaging-based Assessment (Shear Wave Elastography):

    Shear Wave Elastography (SWE) will be utilized to non-invasively quantify the mechanical properties of the ACL. The assessment will focus on:

    Shear Wave Speed (m/s) Shear Modulus (kPa) These metrics serve as direct indicators of tissue stiffness and structural integrity. Measurements will be taken with the knee in a consistent, standardized position to ensure reproducibility.

  2. Functional Biomechanical Performance (Countermovement Jump):

Participants will perform Countermovement Jumps (CMJ) on KFORCE force plates to evaluate lower limb dynamic performance. This functional test provides insight into the athlete's neuromuscular status. Key variables collected will include:

Jump Height (cm) Reactive Strength Index (RSI): Calculated as the ratio of jump height to ground contact time.

Force Metrics: Including eccentric and concentric impulse to analyze force production and absorption strategies.

[Research Goal] By integrating imaging-based mechanical data with functional biomechanical outcomes, this study seeks to identify potential "fatigue" markers or adaptive responses in the ACL resulting from seasonal athletic demands. The findings aim to bridge the gap between clinical imaging and athletic performance, ultimately informing individualized injury prevention strategies and early detection protocols for female athletes at risk.

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Taishan District
      • New Taipei City, Taishan District, Taiwan, 243
        • FJUH Institutional Review Board

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Elite female collegiate basketball teams

Description

Inclusion Criteria:

  • Female collegiate basketball players currently active in Division I
  • Aged between 18 and 35 years
  • At least 5 years of formal basketball training experience
  • No prior history of anterior cruciate ligament (ACL) rupture in either knee
  • Ability to participate in both pre-season and post-season testing sessions

Exclusion Criteria:

  • Lower limb injury during the study period resulting in interruption of training for one month or longer
  • Bilateral knee surgery for any reason during the course of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ACL Shear Modulus
Time Frame: Baseline and at the end of the competitive season (approximately 6 months)
The shear modulus of the anterior cruciate ligament (ACL) will be measured using shear wave elastography (SWE). This value serves as a quantitative indicator of ligament tissue stiffness.
Baseline and at the end of the competitive season (approximately 6 months)
ACL Shear Wave Speed
Time Frame: Baseline and at the end of the competitive season (approximately 6 months)
The velocity of shear waves propagating through the ACL tissue, measured via SWE. This value is used to evaluate the structural integrity and density of the ligament tissue.
Baseline and at the end of the competitive season (approximately 6 months)
Reactive Strength Index (RSI)
Time Frame: Baseline and at the end of the competitive season (approximately 6 months)
Calculated as the ratio of jump height to ground contact time (RSI = jump height / ground contact time) during a countermovement jump (CMJ). This index evaluates the explosive power and neuromuscular control of the lower limbs.
Baseline and at the end of the competitive season (approximately 6 months)
Countermovement Jump (CMJ) Height
Time Frame: Baseline and at the end of the competitive season (approximately 6 months)
The maximum vertical displacement of the center of mass during a countermovement jump, measured using KFORCE force plates.
Baseline and at the end of the competitive season (approximately 6 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 30, 2025

Primary Completion (Estimated)

April 30, 2026

Study Completion (Estimated)

July 30, 2026

Study Registration Dates

First Submitted

March 5, 2026

First Submitted That Met QC Criteria

March 17, 2026

First Posted (Actual)

March 20, 2026

Study Record Updates

Last Update Posted (Actual)

March 20, 2026

Last Update Submitted That Met QC Criteria

March 17, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Cruciate Ligament Injuries

Subscribe